Pharma · Private company
Sanofi Pasteur, a Sanofi Company
Track this companyFree. Adds Sanofi Pasteur, a Sanofi Company to your Dealase workspace and tells you when its record changes.
Clinical trials258 recruiting or active
Pipeline programs64From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline64
- 20vPCVPhase 3 · Pneumococcal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Hepatitis B vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- High-Dose trivalent influenza vaccine (Split virion, Inactivated)Phase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- M-M-R II vaccinePhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- PCV21Phase 3 · Pneumococcal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- PCV21 vaccinePhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Prevnar 20 vaccinePhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent influenza vaccine, high-dosePhase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent influenza vaccine, standard dosePhase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- RotaTeqPhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Rotavirus vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- RSVt vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- RSVt VaccinePhase 3 · RSV ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- SARS-CoV-2 adjuvanted recombinant protein vaccine (bivalent D614 + B.1.351) (primary series)Phase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent B.1.351) (booster dose) >= 4 months after last vaccinationPhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)Phase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Standard-dose trivalent influenza vaccine (Split virion, Inactivated)Phase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Streptococcus pneumoniae vaccinePhase 3 · RSV ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- VarivaxPhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Vaxelis vaccinePhase 3 · Pneumococcal ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Acne mRNA vaccinePhase 2 · AcneClinicalTrials.gov · fetched Nov 12, 2026
- Control GroupPhase 2 · Respiratory Syncytial Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Investigational hMPV vaccine (monovalent)Phase 2 · Human Metapneumovirus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Investigational hMPV/RSV vaccinePhase 2 · Human Metapneumovirus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Investigational RSV vaccine (monovalent)Phase 2 · Human Metapneumovirus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Investigational RSV+hMPV vaccinePhase 2 · Human Metapneumovirus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Licensed RSV VaccinePhase 2 · Human Metapneumovirus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- MenACYW conjugate vaccinePhase 2 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Meningococcal group B vaccinePhase 2 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Panblok + MF59 Dose 1Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Panblok + MF59 Dose 2Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Pandemic flu H5 mRNA vaccinePhase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Pentavalent Meningococcal ABCYW vaccinePhase 2 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza High-Dose VaccinePhase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza mRNA Vaccine MRT5421Phase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza mRNA Vaccine MRT5424Phase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza mRNA Vaccine MRT5429Phase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza Standard Dose VaccinePhase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Influenza Standard Dose VaccinePhase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Quadrivalent Recombinant Influenza VaccinePhase 2 · Influenza ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- RSV vaccine candidatePhase 2 · Respiratory Syncytial Virus ImmunizationClinicalTrials.gov · fetched Nov 12, 2026
- RSV/hMPV vaccine candidate Dose APhase 2 · Respiratory Syncytial Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RSV/hMPV vaccine candidate Dose BPhase 2 · Respiratory Syncytial Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RSV/hMPV vaccine candidate Dose LPhase 2 · Respiratory Syncytial Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RSVt VaccinePhase 2 · Respiratory Syncytial Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TIV mRNA-HA Vaccine 2Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- TIV mRNA-neuraminidase (NA)Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Unadjuvanted Panblok Dose 3Phase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccinePhase 2 · Yellow FeverClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccine (produced on serum-free Vero cells)Phase 2 · Yellow FeverClinicalTrials.gov · fetched Nov 12, 2026
- Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)Phase 1 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Meningococcal Group B Vaccine MenBPhase 1 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccinePhase 1 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Multicomponent Meningococcal B VaccinePhase 1 · Meningococcal ImmunisationClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccinePhase 1 · Yellow Fever (Healthy Volunteers)ClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccine (produced on serum-free Vero cells), Dosage 1 vYF vaccinePhase 1 · Yellow Fever (Healthy Volunteers)ClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccine (produced on serum-free Vero cells), Dosage 2 vYF vaccinePhase 1 · Yellow Fever (Healthy Volunteers)ClinicalTrials.gov · fetched Nov 12, 2026
- Yellow fever vaccine (produced on serum-free Vero cells), Dosage 3 vYF vaccinePhase 1 · Yellow Fever (Healthy Volunteers)ClinicalTrials.gov · fetched Nov 12, 2026
- Investigational ProcedurePeriodontal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccineMeningococcal InfectionClinicalTrials.gov · fetched Nov 12, 2026
- NirsevimabRespiratory Syncytial VirusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Flu COVID Vaccine ViewsNOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07871448 · fetched Nov 12, 2026
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcnePHASE1_PHASE2 · RECRUITING · started Jul 3, 2025ClinicalTrials.gov NCT07013747 · fetched Nov 12, 2026
- Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and AdolescentsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 28, 2025ClinicalTrials.gov NCT06838000 · fetched Nov 12, 2026
- A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderPHASE1_PHASE2 · COMPLETED · started Jan 6, 2025ClinicalTrials.gov NCT06744205 · fetched Nov 12, 2026
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgePHASE3 · ACTIVE_NOT_RECRUITING · started Dec 18, 2024ClinicalTrials.gov NCT06736041 · fetched Nov 12, 2026
- Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and OlderPHASE1_PHASE2 · COMPLETED · started Dec 9, 2024ClinicalTrials.gov NCT06727058 · fetched Nov 12, 2026
- Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and OlderPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 11, 2024ClinicalTrials.gov NCT06686654 · fetched Nov 12, 2026
- Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of AgePHASE3 · COMPLETED · started Nov 4, 2024ClinicalTrials.gov NCT06641180 · fetched Nov 12, 2026
- Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of AgeNA · COMPLETED · started Oct 9, 2024ClinicalTrials.gov NCT06582056 · fetched Nov 12, 2026
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersPHASE3 · TERMINATED · started May 13, 2024ClinicalTrials.gov NCT06397768 · fetched Nov 12, 2026
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcnePHASE1_PHASE2 · RECRUITING · started Apr 5, 2024ClinicalTrials.gov NCT06316297 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AbovePHASE1_PHASE2 · COMPLETED · started Apr 1, 2024ClinicalTrials.gov NCT06361875 · fetched Nov 12, 2026
- BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)COMPLETED · started Apr 1, 2024ClinicalTrials.gov NCT06325332 · fetched Nov 12, 2026
- Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersPHASE3 · TERMINATED · started Feb 6, 2024ClinicalTrials.gov NCT06252285 · fetched Nov 12, 2026
- Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidatePHASE1_PHASE2 · COMPLETED · started Nov 1, 2023ClinicalTrials.gov NCT06134648 · fetched Nov 12, 2026
- Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and AdolescentsPHASE1_PHASE2 · COMPLETED · started Oct 31, 2023ClinicalTrials.gov NCT06128733 · fetched Nov 12, 2026
- Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)PHASE1_PHASE2 · COMPLETED · started Feb 6, 2023ClinicalTrials.gov NCT05687279 · fetched Nov 12, 2026
- Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and OlderPHASE1_PHASE2 · COMPLETED · started Nov 17, 2022ClinicalTrials.gov NCT05639894 · fetched Nov 12, 2026
- Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and OlderPHASE1_PHASE2 · COMPLETED · started Nov 3, 2022ClinicalTrials.gov NCT05608005 · fetched Nov 12, 2026
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 1, 2021ClinicalTrials.gov NCT04942210 · fetched Nov 12, 2026
- Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderPHASE3 · TERMINATED · started May 26, 2021ClinicalTrials.gov NCT04904549 · fetched Nov 12, 2026
- Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and InfantsPHASE1 · TERMINATED · started Mar 29, 2021ClinicalTrials.gov NCT04825223 · fetched Nov 12, 2026
- Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)RECRUITING · started Mar 5, 2021ClinicalTrials.gov NCT04843111 · fetched Nov 12, 2026
- Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgePHASE3 · TERMINATED · started Sep 15, 2020ClinicalTrials.gov NCT04544267 · fetched Nov 12, 2026
- Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsPHASE1 · COMPLETED · started Jan 15, 2020ClinicalTrials.gov NCT04142086 · fetched Nov 12, 2026